IRON

IRON was reported 67651 times

IRON is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 52 0.1912
1 GRANULOMA SKIN 97 0.1181
2 BLOOD PARATHYROID HORMONE DECREASED 104 0.0701
3 BLOOD IRON DECREASED 776 0.0653
4 IRON DEFICIENCY 207 0.0460
5 BLOOD PRESSURE DIASTOLIC ABNORMAL 117 0.0460
6 SERUM FERRITIN DECREASED 78 0.0451
7 THERAPEUTIC REACTION TIME DECREASED 119 0.0408
8 PANNICULITIS 97 0.0400
9 BLOOD PRESSURE SYSTOLIC ABNORMAL 96 0.0388
10 HYPERPARATHYROIDISM SECONDARY 93 0.0371
11 RHEUMATOID NODULE 102 0.0370
12 IRON DEFICIENCY ANAEMIA 300 0.0325
13 DRUG TOLERANCE DECREASED 88 0.0313
14 FAECAL CALPROTECTIN INCREASED 93 0.0293
15 SINUS PAIN 67 0.0287
16 NEPHROGENIC ANAEMIA 131 0.0283
17 BLOOD IRON INCREASED 52 0.0277
18 INFUSION SITE BRUISING 59 0.0273
19 BREATH SOUNDS ABNORMAL 133 0.0269
20 NEPHROGENIC SYSTEMIC FIBROSIS 80 0.0264
21 VASCULAR DEVICE INFECTION 120 0.0264
22 MUCOUS STOOLS 131 0.0264
23 ANAL FISSURE 137 0.0255
24 INFUSION SITE HAEMORRHAGE 84 0.0255
25 PREMATURE LABOUR 144 0.0254
26 LARGE INTESTINAL STENOSIS 50 0.0250
27 DEFAECATION URGENCY 174 0.0248
28 HYPERPHOSPHATAEMIA 51 0.0237
29 POLYP 154 0.0235
30 DRUG LEVEL BELOW THERAPEUTIC 129 0.0234
31 RHEUMATOID FACTOR POSITIVE 133 0.0230
32 POOR VENOUS ACCESS 237 0.0229
33 INTESTINAL STENOSIS 96 0.0227
34 BLOOD PRESSURE DIASTOLIC DECREASED 168 0.0227
35 DRUG LEVEL DECREASED 215 0.0211
36 FREQUENT BOWEL MOVEMENTS 564 0.0209
37 COLITIS ULCERATIVE 930 0.0208
38 UTERINE LEIOMYOMA 150 0.0205
39 BLOOD PHOSPHORUS INCREASED 56 0.0205
40 FAECES SOFT 144 0.0198
41 MATERNAL EXPOSURE DURING BREAST FEEDING 80 0.0197
42 SKIN NECROSIS 102 0.0196
43 GASTROINTESTINAL INFLAMMATION 154 0.0196
44 ABDOMINAL ADHESIONS 62 0.0196
45 AORTIC STENOSIS 68 0.0195
46 FAECES DISCOLOURED 414 0.0191
47 HAEMATOCHEZIA 1052 0.0190
48 INFUSION SITE SWELLING 119 0.0189
49 ARTHRITIS INFECTIVE 87 0.0187
50 LARGE INTESTINE POLYP 127 0.0183
51 VITAMIN D DECREASED 155 0.0181
52 BLOOD PRESSURE FLUCTUATION 429 0.0179
53 RED BLOOD CELL SEDIMENTATION RATE INCREASED 197 0.0178
54 VITAMIN B12 DECREASED 51 0.0177
55 INFUSION SITE PRURITUS 55 0.0174
56 LOSS OF THERAPEUTIC RESPONSE 55 0.0172
57 CLOSTRIDIUM DIFFICILE INFECTION 368 0.0168
58 APLASIA PURE RED CELL 58 0.0168
59 HAEMOGLOBIN DECREASED 1723 0.0168
60 SEASONAL ALLERGY 237 0.0167
61 PRE-EXISTING CONDITION IMPROVED 104 0.0166
62 HYPOPHOSPHATAEMIA 122 0.0165
63 FULL BLOOD COUNT ABNORMAL 174 0.0164
64 DYSCHEZIA 50 0.0164
65 PRE-ECLAMPSIA 77 0.0162
66 CROHN'S DISEASE 110 0.0160
67 CHRONIC SINUSITIS 60 0.0160
68 FAECES HARD 62 0.0159
69 BLOOD PRESSURE SYSTOLIC INCREASED 310 0.0159
70 BLOOD ALBUMIN DECREASED 126 0.0159
71 ABNORMAL FAECES 130 0.0158
72 BLOOD PRESSURE DIASTOLIC INCREASED 73 0.0158
73 HAEMORRHOIDAL HAEMORRHAGE 76 0.0155
74 BODY TEMPERATURE DECREASED 153 0.0155
75 PREMATURE DELIVERY 241 0.0151
76 HAEMATOCRIT DECREASED 299 0.0151
77 SPUTUM DISCOLOURED 143 0.0151
78 INFUSION SITE ERYTHEMA 127 0.0150
79 SUBCUTANEOUS ABSCESS 72 0.0150
80 APPETITE DISORDER 99 0.0149
81 MATERNAL EXPOSURE BEFORE PREGNANCY 102 0.0149
82 FISTULA 166 0.0148
83 DRUG SPECIFIC ANTIBODY PRESENT 96 0.0147
84 PURULENT DISCHARGE 63 0.0147
85 ABDOMINAL HERNIA 67 0.0147
86 WEIGHT FLUCTUATION 153 0.0146
87 UPPER-AIRWAY COUGH SYNDROME 120 0.0146
88 INTESTINAL RESECTION 78 0.0145
89 RED BLOOD CELL COUNT DECREASED 413 0.0144
90 HAEMORRHAGIC ANAEMIA 63 0.0143
91 WOUND HAEMORRHAGE 53 0.0143
92 HAEMOGLOBIN INCREASED 65 0.0142
93 LOW BIRTH WEIGHT BABY 113 0.0142
94 ANAEMIA 2697 0.0141
95 BLOOD URIC ACID INCREASED 81 0.0140
96 ANAL INCONTINENCE 126 0.0140
97 BLOOD COUNT ABNORMAL 212 0.0140
98 SKIN ABRASION 66 0.0140
99 DIARRHOEA HAEMORRHAGIC 130 0.0139
100 MALNUTRITION 155 0.0138
101 HAEMORRHOIDS 270 0.0138
102 HAEMOGLOBIN ABNORMAL 89 0.0138
103 ULCER 220 0.0138
104 APHTHOUS ULCER 107 0.0138
105 DYSLIPIDAEMIA 70 0.0138
106 RED CELL DISTRIBUTION WIDTH INCREASED 57 0.0137
107 BASAL CELL CARCINOMA 214 0.0137
108 BOWEL MOVEMENT IRREGULARITY 105 0.0137
109 TRANSFUSION 143 0.0136
110 VAGINAL INFECTION 64 0.0136
111 PROCTALGIA 87 0.0135
112 PLATELET COUNT INCREASED 176 0.0135
113 ANAL FISTULA 72 0.0135
114 INFUSION SITE PAIN 173 0.0134
115 LIVE BIRTH 112 0.0134
116 ARTHROPOD BITE 99 0.0133
117 ABDOMINAL ABSCESS 59 0.0133
118 NORMAL NEWBORN 72 0.0132
119 SMALL INTESTINAL OBSTRUCTION 163 0.0132
120 RESPIRATORY RATE INCREASED 117 0.0132
121 INFUSION SITE EXTRAVASATION 82 0.0132
122 PARANASAL SINUS HYPERSECRETION 50 0.0131
123 DRUG LEVEL ABOVE THERAPEUTIC 60 0.0131
124 RENAL FAILURE CHRONIC 100 0.0130
125 HEAVY MENSTRUAL BLEEDING 117 0.0130
126 UTERINE HAEMORRHAGE 55 0.0129
127 MULTIPLE ALLERGIES 101 0.0129
128 BLOOD MAGNESIUM DECREASED 111 0.0128
129 TENDERNESS 132 0.0127
130 HIATUS HERNIA 164 0.0127
131 CYSTIC FIBROSIS 70 0.0126
132 FUNGAL SKIN INFECTION 51 0.0126
133 SLEEP APNOEA SYNDROME 241 0.0126
134 PATENT DUCTUS ARTERIOSUS 50 0.0126
135 RALES 73 0.0126
136 SYNOVIAL CYST 58 0.0125
137 OBSTRUCTION 50 0.0125
138 RECTAL HAEMORRHAGE 528 0.0123
139 FINGER DEFORMITY 59 0.0122
140 BLOOD POTASSIUM DECREASED 366 0.0122
141 GESTATIONAL DIABETES 58 0.0122
142 CAESAREAN SECTION 141 0.0121
143 INTERNAL HAEMORRHAGE 138 0.0121
144 END STAGE RENAL DISEASE 219 0.0120
145 HYPERVOLAEMIA 59 0.0119
146 FULL BLOOD COUNT DECREASED 240 0.0119
147 CARDIAC MURMUR 103 0.0119
148 BODY HEIGHT DECREASED 127 0.0119
149 MALABSORPTION 62 0.0119
150 RENAL CYST 94 0.0118
151 DYSPNOEA EXERTIONAL 445 0.0118
152 SPLENOMEGALY 138 0.0118
153 PULMONARY FIBROSIS 225 0.0117
154 LOCALISED OEDEMA 54 0.0117
155 DECUBITUS ULCER 95 0.0116
156 HEART RATE DECREASED 408 0.0116
157 BLOOD CALCIUM DECREASED 130 0.0115
158 NOCTURIA 139 0.0114
159 OSTEOARTHRITIS 485 0.0114
160 INTENTIONAL PRODUCT USE ISSUE 1001 0.0114
161 INCREASED TENDENCY TO BRUISE 105 0.0114
162 MENORRHAGIA 224 0.0114
163 ULCER HAEMORRHAGE 77 0.0114
164 SERUM FERRITIN INCREASED 60 0.0114
165 AMMONIA INCREASED 58 0.0114
166 SKIN WARM 66 0.0113
167 HYPERCALCAEMIA 140 0.0113
168 SKIN ULCER 293 0.0113
169 INTESTINAL OBSTRUCTION 427 0.0113
170 SYNOVITIS 202 0.0112
171 GASTROENTERITIS VIRAL 202 0.0112
172 DIZZINESS POSTURAL 108 0.0111
173 SINUS DISORDER 218 0.0110
174 TOOTH INFECTION 145 0.0110
175 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 527 0.0110
176 POST PROCEDURAL INFECTION 89 0.0109
177 VIRAL UPPER RESPIRATORY TRACT INFECTION 52 0.0109
178 SPINAL OSTEOARTHRITIS 95 0.0108
179 OVERWEIGHT 58 0.0108
180 PELVIC FRACTURE 84 0.0108
181 ANAL ABSCESS 58 0.0108
182 INTERVERTEBRAL DISC DEGENERATION 99 0.0107
183 RESTLESS LEGS SYNDROME 193 0.0106
184 VEIN DISORDER 53 0.0106
185 PRODUCTIVE COUGH 504 0.0105
186 FOETAL GROWTH RESTRICTION 64 0.0105
187 MENSTRUAL DISORDER 87 0.0105
188 ENERGY INCREASED 62 0.0105
189 KIDNEY INFECTION 206 0.0105
190 EAR PAIN 203 0.0104
191 SINUS CONGESTION 141 0.0104
192 LIGAMENT SPRAIN 103 0.0104
193 FAILURE TO THRIVE 54 0.0104
194 ESCHERICHIA INFECTION 85 0.0103
195 PRODUCT ADMINISTRATION INTERRUPTED 81 0.0103
196 NASAL CONGESTION 605 0.0103
197 PREGNANCY 206 0.0103
198 CLOSTRIDIUM DIFFICILE COLITIS 109 0.0103
199 PULMONARY MASS 152 0.0102
200 LIMB INJURY 277 0.0102
201 DERMATITIS CONTACT 116 0.0102
202 ONYCHOCLASIS 70 0.0102
203 BLOOD POTASSIUM INCREASED 165 0.0102
204 OXYGEN SATURATION DECREASED 571 0.0102
205 ABDOMINAL PAIN 2359 0.0101
206 CYSTITIS 322 0.0101
207 PREMATURE BABY 304 0.0101
208 GASTROINTESTINAL PAIN 111 0.0101
209 CONCUSSION 78 0.0101
210 FLUID RETENTION 511 0.0100
211 HYSTERECTOMY 87 0.0100
212 GASTROINTESTINAL INFECTION 90 0.0100
213 DECREASED ACTIVITY 108 0.0100
214 LOCALISED INFECTION 242 0.0100
215 HEART RATE IRREGULAR 226 0.0100
216 SINUSITIS 1023 0.0100
217 CHRONIC KIDNEY DISEASE 755 0.0099
218 BLOOD CALCIUM INCREASED 87 0.0099
219 ABSCESS 158 0.0099
220 INSURANCE ISSUE 151 0.0099
221 WHITE BLOOD CELL COUNT ABNORMAL 63 0.0099
222 CYST 122 0.0098
223 FLATULENCE 556 0.0098
224 VITAMIN D DEFICIENCY 94 0.0096
225 ARTHRITIS 757 0.0096
226 PHARYNGITIS STREPTOCOCCAL 104 0.0096
227 EXPOSURE DURING PREGNANCY 597 0.0096
228 GASTROOESOPHAGEAL REFLUX DISEASE 771 0.0096
229 EAR DISCOMFORT 98 0.0095
230 GASTROINTESTINAL MOTILITY DISORDER 51 0.0095
231 URINARY TRACT INFECTION 1625 0.0095
232 FOOD POISONING 51 0.0095
233 GASTROINTESTINAL HAEMORRHAGE 795 0.0095
234 VIRAL INFECTION 316 0.0095
235 LOWER GASTROINTESTINAL HAEMORRHAGE 70 0.0095
236 RHINORRHOEA 612 0.0095
237 NIGHT SWEATS 305 0.0095
238 ARTHROPATHY 526 0.0095
239 PHARYNGITIS 117 0.0094
240 BRONCHITIS 698 0.0094
241 ATELECTASIS 91 0.0094
242 RESPIRATORY SYNCYTIAL VIRUS INFECTION 82 0.0094
243 HERNIA 182 0.0094
244 PULMONARY HYPERTENSION 196 0.0094
245 WALKING AID USER 62 0.0094
246 SCIATICA 149 0.0093
247 HEART RATE INCREASED 923 0.0093
248 ATRIAL SEPTAL DEFECT 78 0.0093
249 BLADDER DISORDER 92 0.0093
250 VENTRICULAR SEPTAL DEFECT 53 0.0092
251 LYMPHOEDEMA 64 0.0092
252 IMPAIRED QUALITY OF LIFE 133 0.0092
253 PULMONARY ARTERIAL HYPERTENSION 134 0.0092
254 HYPERKERATOSIS 51 0.0092
255 OSTEOPENIA 140 0.0092
256 DENTAL CARIES 102 0.0092
257 COLECTOMY 52 0.0092
258 WEIGHT DECREASED 2567 0.0092
259 POSTOPERATIVE WOUND INFECTION 62 0.0092
260 WRIST FRACTURE 110 0.0092
261 CONTUSION 882 0.0092
262 URINE OUTPUT DECREASED 80 0.0091
263 CARPAL TUNNEL SYNDROME 128 0.0091
264 VAGINAL HAEMORRHAGE 396 0.0091
265 GASTROENTERITIS 133 0.0091
266 NEPHROPATHY 85 0.0091
267 CARDIAC VALVE DISEASE 52 0.0091
268 RIB FRACTURE 187 0.0091
269 TOOTH FRACTURE 100 0.0091
270 INGUINAL HERNIA 55 0.0090
271 MYASTHENIA GRAVIS 73 0.0090
272 GOUT 162 0.0090
273 ORAL PAIN 202 0.0090
274 DIVERTICULUM 64 0.0090
275 FLUID OVERLOAD 131 0.0090
276 EOSINOPHIL COUNT INCREASED 75 0.0090
277 JOINT STIFFNESS 236 0.0090
278 TOOTH ABSCESS 91 0.0089
279 BLOOD URINE PRESENT 169 0.0089
280 OBSTRUCTIVE AIRWAYS DISORDER 99 0.0089
281 PERIPHERAL SWELLING 1370 0.0089
282 CARDIAC PACEMAKER INSERTION 53 0.0089
283 CONSTIPATION 1936 0.0089
284 ROTATOR CUFF SYNDROME 114 0.0089
285 NASOPHARYNGITIS 1635 0.0089
286 BLOOD DISORDER 71 0.0089
287 C-REACTIVE PROTEIN INCREASED 322 0.0088
288 MATERNAL EXPOSURE DURING PREGNANCY 787 0.0088
289 UPPER RESPIRATORY TRACT INFECTION 407 0.0088
290 HAEMOLYSIS 68 0.0088
291 OROPHARYNGEAL PAIN 815 0.0088
292 OVARIAN CYST 88 0.0088
293 GASTRIC ULCER 167 0.0088
294 PALLOR 239 0.0088
295 FEEDING DISORDER 178 0.0088
296 MUSCULOSKELETAL DISCOMFORT 151 0.0088
297 ATRIAL FLUTTER 70 0.0088
298 SCOLIOSIS 54 0.0087
299 FURUNCLE 69 0.0087
300 HYPERSOMNIA 249 0.0087
301 RESPIRATORY TRACT CONGESTION 138 0.0087
302 UPPER GASTROINTESTINAL HAEMORRHAGE 146 0.0087
303 BLOOD PRESSURE INCREASED 1318 0.0086
304 HYPERLIPIDAEMIA 103 0.0086
305 BLOOD TEST ABNORMAL 121 0.0086
306 HAND FRACTURE 61 0.0086
307 MUSCULOSKELETAL CHEST PAIN 133 0.0086
308 OEDEMA PERIPHERAL 1044 0.0086
309 INFLAMMATION 442 0.0086
310 ABDOMINAL DISTENSION 893 0.0085
311 SOMNAMBULISM 56 0.0085
312 TASTE DISORDER 173 0.0085
313 DYSMENORRHOEA 113 0.0085
314 PAIN IN JAW 241 0.0085
315 RESPIRATORY TRACT INFECTION 221 0.0085
316 MUSCULOSKELETAL STIFFNESS 742 0.0085
317 HIP FRACTURE 272 0.0084
318 NASAL DRYNESS 53 0.0084
319 MASS 118 0.0084
320 PLATELET COUNT ABNORMAL 51 0.0084
321 RASH PRURITIC 456 0.0084
322 FEELING COLD 234 0.0084
323 SKIN LESION 230 0.0084
324 SKIN INFECTION 94 0.0084
325 NEPHROLITHIASIS 384 0.0084
326 BREAST MASS 56 0.0083
327 BLOOD SODIUM DECREASED 156 0.0083
328 TOOTH DISORDER 184 0.0083
329 C-REACTIVE PROTEIN ABNORMAL 53 0.0083
330 NERVE COMPRESSION 76 0.0082
331 EAR INFECTION 219 0.0082
332 EXOSTOSIS 75 0.0082
333 DYSSTASIA 239 0.0082
334 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 427 0.0082
335 GALLBLADDER DISORDER 146 0.0082
336 CHOLELITHIASIS 268 0.0082
337 BRAIN FOG 128 0.0082
338 EYE INFECTION 92 0.0081
339 JOINT INJURY 174 0.0081
340 JOINT DISLOCATION 86 0.0081
341 INFUSION RELATED REACTION 538 0.0081
342 NEURALGIA 197 0.0081
343 SKIN DISORDER 270 0.0081
344 SKIN LACERATION 88 0.0081
345 EPISTAXIS 605 0.0081
346 PRODUCT DISTRIBUTION ISSUE 75 0.0081
347 SCRATCH 85 0.0081
348 NODULE 105 0.0080
349 FOOT DEFORMITY 89 0.0080
350 CORONARY ARTERY OCCLUSION 110 0.0080
351 HEAD DISCOMFORT 142 0.0080
352 DEHYDRATION 1069 0.0080
353 MICTURITION URGENCY 91 0.0080
354 APHONIA 111 0.0079
355 NECK PAIN 444 0.0079
356 WOUND 222 0.0079
357 CELLULITIS 400 0.0079
358 FATIGUE 6175 0.0079
359 CATARACT 472 0.0079
360 ASTHENIA 2979 0.0079
361 PRESCRIBED UNDERDOSE 158 0.0079
362 HYPERAESTHESIA 65 0.0079
363 JOINT RANGE OF MOTION DECREASED 106 0.0079
364 OSTEOMYELITIS 143 0.0079
365 LOWER RESPIRATORY TRACT INFECTION 359 0.0079
366 SNEEZING 177 0.0079
367 WEIGHT INCREASED 1766 0.0079
368 INCONTINENCE 83 0.0078
369 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 133 0.0078
370 BACK PAIN 1817 0.0078
371 APPENDICITIS 73 0.0078
372 DIARRHOEA 5037 0.0078
373 RETCHING 166 0.0078
374 ABNORMAL LOSS OF WEIGHT 53 0.0078
375 BLOOD PRESSURE DECREASED 516 0.0078
376 HOT FLUSH 585 0.0078
377 ANKLE FRACTURE 120 0.0077
378 ECCHYMOSIS 53 0.0077
379 SUPRAVENTRICULAR TACHYCARDIA 74 0.0077
380 FALL 2572 0.0077
381 THIRST 138 0.0077
382 BACTERIAL INFECTION 144 0.0077
383 ARTHRALGIA 3201 0.0077
384 COAGULOPATHY 128 0.0077
385 HYPOPHAGIA 195 0.0076
386 ILLNESS 785 0.0076
387 THERAPEUTIC RESPONSE SHORTENED 252 0.0076
388 MITRAL VALVE INCOMPETENCE 86 0.0076
389 HOSPICE CARE 75 0.0076
390 ABDOMINAL PAIN LOWER 192 0.0076
391 LABORATORY TEST ABNORMAL 224 0.0076
392 ATRIAL FIBRILLATION 739 0.0076
393 INFLUENZA 846 0.0076
394 OSTEOPOROSIS 312 0.0076
395 FLANK PAIN 71 0.0076
396 COUGH 2121 0.0076
397 SKIN HAEMORRHAGE 112 0.0075
398 DRUG EXPOSURE DURING PREGNANCY 257 0.0075
399 LACERATION 71 0.0075
400 OEDEMA 409 0.0075
401 FUNGAL INFECTION 251 0.0075
402 SKIN DISCOLOURATION 346 0.0075
403 MUSCLE STRAIN 65 0.0075
404 TROPONIN INCREASED 57 0.0075
405 PARKINSONISM 73 0.0075
406 HAIR TEXTURE ABNORMAL 100 0.0075
407 JOINT SWELLING 901 0.0075
408 MACULAR DEGENERATION 89 0.0074
409 PHOTOPHOBIA 140 0.0074
410 TRICUSPID VALVE INCOMPETENCE 59 0.0074
411 GAIT INABILITY 248 0.0074
412 BONE DISORDER 135 0.0074
413 JOINT EFFUSION 51 0.0074
414 DRUG ERUPTION 131 0.0074
415 CONDITION AGGRAVATED 2240 0.0074
416 STAPHYLOCOCCAL INFECTION 243 0.0074
417 TEMPERATURE INTOLERANCE 76 0.0074
418 INTERVERTEBRAL DISC PROTRUSION 161 0.0074
419 HEREDITARY ANGIOEDEMA 79 0.0074
420 CARDIAC FAILURE CONGESTIVE 591 0.0074
421 FOOT FRACTURE 139 0.0073
422 HYPOALBUMINAEMIA 57 0.0073
423 TONGUE DISORDER 53 0.0073
424 CARDIOMEGALY 90 0.0073
425 ELECTROLYTE IMBALANCE 85 0.0073
426 WOUND INFECTION 80 0.0073
427 POST PROCEDURAL HAEMORRHAGE 85 0.0073
428 SCAR 125 0.0073
429 PNEUMONIA BACTERIAL 67 0.0073
430 TOOTHACHE 132 0.0073
431 GROIN PAIN 64 0.0073
432 DYSPHONIA 426 0.0073
433 CHOLECYSTECTOMY 83 0.0073
434 POLLAKIURIA 303 0.0073
435 FOOD ALLERGY 56 0.0072
436 COELIAC DISEASE 71 0.0072
437 HAIR COLOUR CHANGES 90 0.0072
438 COLITIS 274 0.0072
439 PERICARDIAL EFFUSION 167 0.0072
440 DECREASED APPETITE 1677 0.0072
441 PULMONARY OEDEMA 323 0.0072
442 PNEUMONIA 2333 0.0072
443 BLOOD PRESSURE ABNORMAL 143 0.0072
444 IMPAIRED HEALING 236 0.0072
445 SECRETION DISCHARGE 90 0.0072
446 BODY TEMPERATURE INCREASED 146 0.0071
447 PULMONARY THROMBOSIS 78 0.0071
448 THROMBOSIS 575 0.0071
449 PERIPHERAL COLDNESS 98 0.0071
450 SPINAL COMPRESSION FRACTURE 59 0.0071
451 RHEUMATOID ARTHRITIS 809 0.0071
452 ORAL HERPES 139 0.0071
453 CANDIDA INFECTION 120 0.0071
454 UPPER LIMB FRACTURE 141 0.0071
455 MIDDLE INSOMNIA 132 0.0071
456 POOR QUALITY SLEEP 152 0.0071
457 PAIN IN EXTREMITY 2079 0.0070
458 FRUSTRATION TOLERANCE DECREASED 57 0.0070
459 BONE PAIN 413 0.0070
460 HEAD INJURY 223 0.0070
461 LIMB DISCOMFORT 218 0.0070
462 SPINAL FRACTURE 141 0.0070
463 BALANCE DISORDER 608 0.0070
464 HEPATIC CIRRHOSIS 132 0.0070
465 MUSCLE ATROPHY 89 0.0070
466 WHITE BLOOD CELL COUNT INCREASED 269 0.0070
467 SQUAMOUS CELL CARCINOMA 66 0.0070
468 THYROID DISORDER 108 0.0070
469 SENSATION OF FOREIGN BODY 59 0.0070
470 HEPATIC STEATOSIS 130 0.0070
471 MUSCLE SPASMS 1279 0.0070
472 BACK DISORDER 113 0.0069
473 ABDOMINAL DISCOMFORT 1165 0.0069
474 HAEMORRHAGE 724 0.0069
475 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1247 0.0069
476 HAEMATEMESIS 175 0.0069
477 MUSCULOSKELETAL PAIN 361 0.0069
478 CHILLS 807 0.0069
479 RENAL DISORDER 319 0.0068
480 ASCITES 201 0.0068
481 GLOMERULAR FILTRATION RATE DECREASED 84 0.0068
482 FACIAL PAIN 61 0.0068
483 FIBROMYALGIA 166 0.0068
484 POST PROCEDURAL COMPLICATION 131 0.0068
485 EATING DISORDER 145 0.0068
486 HIDRADENITIS 62 0.0068
487 HERPES ZOSTER 389 0.0068
488 CHEST DISCOMFORT 693 0.0068
489 GAIT DISTURBANCE 1294 0.0068
490 DELUSION 105 0.0068
491 CONTRAINDICATED PRODUCT ADMINISTERED 204 0.0067
492 ABDOMINAL PAIN UPPER 1383 0.0067
493 IMMUNODEFICIENCY 100 0.0067
494 HYPOTHYROIDISM 214 0.0067
495 GASTRIC HAEMORRHAGE 77 0.0067
496 HYPERTENSION 1413 0.0067
497 MUSCLE TIGHTNESS 108 0.0067
498 HEPATIC ENZYME INCREASED 453 0.0066
499 DIVERTICULITIS 184 0.0066
500 RASH MACULAR 232 0.0066
501 QUALITY OF LIFE DECREASED 89 0.0066
502 PLATELET COUNT DECREASED 707 0.0066
503 DEVICE RELATED INFECTION 102 0.0066
504 LYMPHOCYTE COUNT DECREASED 117 0.0066
505 IMPAIRED GASTRIC EMPTYING 90 0.0066
506 PULMONARY CONGESTION 87 0.0066
507 MOUTH ULCERATION 139 0.0066
508 INTENTIONAL DOSE OMISSION 188 0.0066
509 TOOTH EXTRACTION 82 0.0066
510 DIZZINESS 3270 0.0065
511 KNEE ARTHROPLASTY 138 0.0065
512 HYPOTENSION 1314 0.0065
513 DYSPEPSIA 644 0.0065
514 EMPHYSEMA 66 0.0065
515 LYMPHADENOPATHY 231 0.0065
516 PLEURAL EFFUSION 397 0.0065
517 THROAT IRRITATION 292 0.0065
518 HYPOAESTHESIA 974 0.0065
519 GASTRITIS 171 0.0065
520 INCREASED APPETITE 124 0.0065
521 THERAPEUTIC PRODUCT EFFECT DECREASED 290 0.0065
522 DYSPNOEA 3660 0.0065
523 DRY MOUTH 524 0.0065
524 PRESYNCOPE 157 0.0065
525 RENAL FAILURE 857 0.0064
526 COVID-19 1130 0.0064
527 DYSURIA 237 0.0064
528 CARDIOMYOPATHY 95 0.0064
529 CHROMATURIA 145 0.0064
530 APNOEA 50 0.0064
531 CHEST PAIN 1188 0.0064
532 WHITE BLOOD CELL COUNT DECREASED 695 0.0064
533 PRODUCT USE COMPLAINT 101 0.0064
534 MELAENA 141 0.0064
535 HEADACHE 4008 0.0064
536 BLOOD UREA INCREASED 107 0.0064
537 SWELLING 598 0.0064
538 HUNGER 89 0.0064
539 HAEMOPTYSIS 178 0.0064
540 URINARY INCONTINENCE 189 0.0064
541 SLEEP DISORDER 450 0.0064
542 SEPSIS 711 0.0064
543 INFECTION 920 0.0063
544 ABASIA 157 0.0063
545 BACK INJURY 69 0.0063
546 DIALYSIS 90 0.0063
547 FLUSHING 644 0.0063
548 OESOPHAGITIS 69 0.0063
549 PROCEDURAL PAIN 175 0.0063
550 GASTROINTESTINAL DISORDER 565 0.0063
551 DRY THROAT 64 0.0063
552 SKIN CANCER 135 0.0063
553 INABILITY TO AFFORD MEDICATION 62 0.0062
554 ACUTE RESPIRATORY FAILURE 120 0.0062
555 PETECHIAE 65 0.0062
556 HEPATOMEGALY 61 0.0062
557 INSOMNIA 1653 0.0062
558 MOVEMENT DISORDER 199 0.0062
559 HAIR DISORDER 51 0.0062
560 LETHARGY 356 0.0062
561 WHEEZING 366 0.0062
562 ARTERIOSCLEROSIS 58 0.0062
563 OFF LABEL USE 5389 0.0061
564 INTESTINAL PERFORATION 69 0.0061
565 PRODUCT DOSE OMISSION IN ERROR 174 0.0061
566 MIGRAINE 585 0.0061
567 DERMATITIS ALLERGIC 77 0.0061
568 FEELING HOT 375 0.0061
569 ALOPECIA 1198 0.0061
570 NAUSEA 4828 0.0061
571 DEEP VEIN THROMBOSIS 396 0.0061
572 AGEUSIA 152 0.0061
573 OROPHARYNGEAL DISCOMFORT 55 0.0061
574 IMMUNE SYSTEM DISORDER 80 0.0061
575 BLOOD CREATININE INCREASED 396 0.0061
576 PARAESTHESIA 954 0.0061
577 PELVIC PAIN 110 0.0060
578 SCAB 69 0.0060
579 VOMITING 2840 0.0060
580 MUSCULAR WEAKNESS 686 0.0060
581 VAGINAL DISCHARGE 61 0.0060
582 RASH PAPULAR 135 0.0060
583 HYPOXIA 212 0.0060
584 PAIN 3685 0.0060
585 PALPITATIONS 700 0.0060
586 ORTHOSTATIC HYPOTENSION 104 0.0060
587 DEAFNESS 156 0.0060
588 LOWER LIMB FRACTURE 114 0.0059
589 PHARYNGEAL SWELLING 58 0.0059
590 BREAST PAIN 63 0.0059
591 HEPATIC ENCEPHALOPATHY 55 0.0059
592 DRUG EFFECT LESS THAN EXPECTED 87 0.0059
593 GINGIVAL BLEEDING 80 0.0059
594 EJECTION FRACTION DECREASED 91 0.0058
595 ORAL CANDIDIASIS 77 0.0058
596 ASPIRATION 64 0.0058
597 ASTHMA 660 0.0058
598 CARDIAC OPERATION 50 0.0058
599 NEUROPATHY PERIPHERAL 553 0.0058
600 PROSTATIC SPECIFIC ANTIGEN INCREASED 80 0.0058
601 STOMATITIS 351 0.0058
602 EYE DISCHARGE 60 0.0058
603 BLOOD THYROID STIMULATING HORMONE INCREASED 53 0.0058
604 FEELING ABNORMAL 1378 0.0057
605 HIP ARTHROPLASTY 88 0.0057
606 UROSEPSIS 53 0.0057
607 EYE PAIN 323 0.0057
608 HAEMATURIA 196 0.0057
609 DEPRESSED MOOD 302 0.0057
610 UNRESPONSIVE TO STIMULI 147 0.0057
611 LACRIMATION INCREASED 172 0.0057
612 BURSITIS 69 0.0057
613 INJECTION SITE DISCOLOURATION 71 0.0057
614 VISION BLURRED 780 0.0057
615 NERVE INJURY 63 0.0057
616 CYANOSIS 89 0.0057
617 MEMORY IMPAIRMENT 775 0.0056
618 THERAPY NON-RESPONDER 253 0.0056
619 LUNG DISORDER 275 0.0056
620 DRUG INTOLERANCE 542 0.0056
621 HYPOTONIA 56 0.0056
622 MALAISE 2458 0.0056
623 PRODUCT USE ISSUE 1050 0.0056
624 HYPERHIDROSIS 718 0.0056
625 SOMNOLENCE 1118 0.0055
626 PULMONARY EMBOLISM 527 0.0055
627 MADAROSIS 64 0.0055
628 HYPOKINESIA 80 0.0055
629 ANXIETY 1564 0.0055
630 MOOD SWINGS 175 0.0055
631 BEDRIDDEN 72 0.0055
632 MOBILITY DECREASED 393 0.0055
633 UVEITIS 74 0.0055
634 SARS-COV-2 TEST POSITIVE 72 0.0054
635 FOETAL EXPOSURE DURING PREGNANCY 443 0.0054
636 TREMOR 904 0.0054
637 INJECTION SITE HAEMATOMA 79 0.0054
638 INJECTION SITE BRUISING 434 0.0054
639 DEPRESSION 1237 0.0054
640 PRURITUS 2085 0.0054
641 TENDONITIS 84 0.0054
642 IRRITABLE BOWEL SYNDROME 116 0.0054
643 RENAL TUBULAR NECROSIS 53 0.0054
644 PYREXIA 1869 0.0054
645 THERAPEUTIC RESPONSE DECREASED 327 0.0054
646 PRODUCT ADMINISTRATION ERROR 109 0.0054
647 THERAPY CHANGE 53 0.0054
648 DRY EYE 269 0.0054
649 INFLUENZA LIKE ILLNESS 443 0.0054
650 RENAL PAIN 57 0.0054
651 HYPOAESTHESIA ORAL 81 0.0054
652 DYSPHAGIA 508 0.0053
653 SWELLING FACE 348 0.0053
654 PRODUCT DOSE OMISSION 348 0.0053
655 PRODUCT DOSE OMISSION ISSUE 1565 0.0053
656 MYALGIA 904 0.0053
657 SYNCOPE 531 0.0053
658 BLISTER 298 0.0053
659 THERAPEUTIC RESPONSE UNEXPECTED 238 0.0053
660 HYPOCALCAEMIA 100 0.0053
661 LOCAL SWELLING 92 0.0053
662 ERUCTATION 102 0.0053
663 SYSTEMIC LUPUS ERYTHEMATOSUS 187 0.0053
664 LOSS OF CONSCIOUSNESS 675 0.0053
665 DIABETES MELLITUS 400 0.0052
666 MENTAL STATUS CHANGES 145 0.0052
667 SKIN FISSURES 102 0.0052
668 THINKING ABNORMAL 97 0.0052
669 CRYING 189 0.0052
670 SURGERY 304 0.0052
671 DISCOMFORT 316 0.0052
672 BLOOD LACTATE DEHYDROGENASE INCREASED 82 0.0052
673 CONJUNCTIVITIS 96 0.0052
674 HYPOMAGNESAEMIA 72 0.0052
675 GENERALISED OEDEMA 64 0.0052
676 MUSCULOSKELETAL DISORDER 98 0.0051
677 VENTRICULAR FIBRILLATION 57 0.0051
678 HYPERGLYCAEMIA 187 0.0051
679 NERVOUSNESS 267 0.0051
680 PNEUMOTHORAX 81 0.0051
681 PANIC ATTACK 186 0.0051
682 COMPLICATION ASSOCIATED WITH DEVICE 74 0.0051
683 BURNING SENSATION 357 0.0051
684 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 362 0.0051
685 AMNESIA 331 0.0051
686 INJECTION SITE RASH 156 0.0051
687 TYPE 2 DIABETES MELLITUS 171 0.0051
688 OCULAR DISCOMFORT 57 0.0051
689 GENERALISED TONIC-CLONIC SEIZURE 84 0.0051
690 DYSGEUSIA 377 0.0051
691 RESPIRATORY DISTRESS 140 0.0051
692 GASTRIC DISORDER 174 0.0051
693 INITIAL INSOMNIA 52 0.0051
694 HAEMATOMA 131 0.0051
695 LEUKOCYTOSIS 91 0.0050
696 RENAL IMPAIRMENT 422 0.0050
697 EYE DISORDER 165 0.0050
698 TUBULOINTERSTITIAL NEPHRITIS 94 0.0050
699 ECONOMIC PROBLEM 76 0.0050
700 INJECTION SITE INDURATION 65 0.0050
701 EYE SWELLING 186 0.0050
702 COLD SWEAT 88 0.0050
703 HALLUCINATION 376 0.0050
704 MUSCLE TWITCHING 115 0.0050
705 FEELING JITTERY 95 0.0050
706 UNEVALUABLE EVENT 376 0.0050
707 CONFUSIONAL STATE 803 0.0050
708 SPEECH DISORDER 259 0.0049
709 GLAUCOMA 95 0.0049
710 INJECTION SITE PRURITUS 330 0.0049
711 ERYTHEMA 1012 0.0049
712 DERMATITIS 103 0.0049
713 COVID-19 PNEUMONIA 58 0.0049
714 PSORIATIC ARTHROPATHY 199 0.0049
715 TINNITUS 225 0.0049
716 ACUTE KIDNEY INJURY 747 0.0049
717 DISTURBANCE IN ATTENTION 262 0.0049
718 FEMUR FRACTURE 150 0.0048
719 PRODUCT AVAILABILITY ISSUE 110 0.0048
720 DEMENTIA 135 0.0048
721 ALANINE AMINOTRANSFERASE INCREASED 296 0.0048
722 METRORRHAGIA 82 0.0048
723 COORDINATION ABNORMAL 67 0.0048
724 CARDIAC DISORDER 449 0.0048
725 ACTIVITIES OF DAILY LIVING IMPAIRED 95 0.0048
726 LIVER FUNCTION TEST INCREASED 103 0.0048
727 VERTIGO 292 0.0048
728 PROTEINURIA 91 0.0048
729 ADRENAL INSUFFICIENCY 58 0.0048
730 COLON CANCER 71 0.0048
731 METASTASES TO LUNG 55 0.0048
732 IMPAIRED DRIVING ABILITY 54 0.0047
733 SKIN EXFOLIATION 400 0.0047
734 TACHYCARDIA 421 0.0047
735 GENERAL PHYSICAL HEALTH DETERIORATION 548 0.0047
736 INTERNATIONAL NORMALISED RATIO INCREASED 135 0.0047
737 ASPARTATE AMINOTRANSFERASE INCREASED 251 0.0047
738 BLOOD GLUCOSE DECREASED 226 0.0047
739 INJECTION SITE PAIN 1438 0.0047
740 ROAD TRAFFIC ACCIDENT 196 0.0047
741 TRANSIENT ISCHAEMIC ATTACK 158 0.0047
742 IMPAIRED WORK ABILITY 100 0.0047
743 APHASIA 141 0.0047
744 OBESITY 74 0.0046
745 THERAPY INTERRUPTED 331 0.0046
746 PRURITUS GENERALISED 100 0.0046
747 DYSARTHRIA 174 0.0046
748 CHOKING 90 0.0046
749 SPINAL PAIN 54 0.0046
750 DRY SKIN 615 0.0046
751 OCULAR HYPERAEMIA 218 0.0046
752 PARANOIA 79 0.0046
753 LUNG INFECTION 71 0.0046
754 HOSPITALISATION 697 0.0045
755 HEPATITIS 116 0.0045
756 URINARY RETENTION 151 0.0045
757 RESTLESSNESS 165 0.0045
758 PARAESTHESIA ORAL 65 0.0045
759 BLOOD CHOLESTEROL INCREASED 210 0.0045
760 EYE HAEMORRHAGE 60 0.0045
761 RASH 1958 0.0045
762 THERAPY PARTIAL RESPONDER 70 0.0045
763 ECZEMA 234 0.0045
764 ABORTION SPONTANEOUS 179 0.0045
765 THERAPY CESSATION 227 0.0044
766 PSYCHOMOTOR HYPERACTIVITY 73 0.0044
767 BLINDNESS UNILATERAL 62 0.0044
768 INJURY 308 0.0044
769 RESPIRATORY DISORDER 131 0.0044
770 THROAT TIGHTNESS 118 0.0044
771 INJECTION SITE ERYTHEMA 541 0.0044
772 BLOOD ALKALINE PHOSPHATASE INCREASED 108 0.0043
773 MALIGNANT MELANOMA 58 0.0043
774 CORONARY ARTERY DISEASE 131 0.0043
775 METASTASES TO BONE 71 0.0043
776 PNEUMONIA ASPIRATION 108 0.0043
777 CARDIOGENIC SHOCK 62 0.0043
778 ORAL DISCOMFORT 60 0.0043
779 ACNE 327 0.0043
780 HYPERKALAEMIA 151 0.0043
781 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 306 0.0043
782 ATAXIA 51 0.0043
783 HYPERSENSITIVITY 796 0.0043
784 DIPLOPIA 111 0.0043
785 ACCIDENT 51 0.0043
786 INJECTION SITE HAEMORRHAGE 341 0.0043
787 FACE OEDEMA 72 0.0043
788 RENAL FAILURE ACUTE 181 0.0043
789 DEVICE OCCLUSION 60 0.0043
790 ANHEDONIA 112 0.0043
791 COGNITIVE DISORDER 199 0.0043
792 VISUAL IMPAIRMENT 524 0.0042
793 BACTERAEMIA 50 0.0042
794 FEAR 113 0.0042
795 PARALYSIS 60 0.0042
796 DEVICE DISLOCATION 182 0.0042
797 HYPOACUSIS 180 0.0042
798 EMOTIONAL DISORDER 128 0.0041
799 RESPIRATORY FAILURE 302 0.0041
800 LIVER DISORDER 183 0.0041
801 COMPLICATION OF DEVICE INSERTION 82 0.0041
802 PHOTOSENSITIVITY REACTION 68 0.0041
803 INCORRECT PRODUCT ADMINISTRATION DURATION 89 0.0041
804 SEIZURE 474 0.0041
805 ACUTE HEPATIC FAILURE 56 0.0041
806 INJECTION SITE IRRITATION 52 0.0041
807 PAIN OF SKIN 110 0.0041
808 DYSKINESIA 166 0.0041
809 MENTAL DISORDER 177 0.0041
810 DISORIENTATION 161 0.0041
811 LIVER FUNCTION TEST ABNORMAL 118 0.0041
812 INJECTION SITE MASS 150 0.0041
813 NEEDLE ISSUE 118 0.0040
814 INJECTION SITE EXTRAVASATION 50 0.0040
815 INJECTION SITE SWELLING 310 0.0040
816 HALLUCINATION, VISUAL 85 0.0040
817 RASH ERYTHEMATOUS 191 0.0040
818 INCORRECT DOSE ADMINISTERED 909 0.0040
819 PLASMA CELL MYELOMA 155 0.0040
820 HYPOKALAEMIA 183 0.0040
821 MOOD ALTERED 108 0.0040
822 ANOSMIA 57 0.0039
823 MUCOSAL INFLAMMATION 103 0.0039
824 GLOSSODYNIA 88 0.0039
825 TREATMENT FAILURE 325 0.0039
826 TACHYPNOEA 53 0.0039
827 WRONG TECHNIQUE IN DRUG USAGE PROCESS 141 0.0039
828 TREATMENT NONCOMPLIANCE 212 0.0039
829 INJECTION SITE URTICARIA 95 0.0039
830 HYPONATRAEMIA 218 0.0039
831 ANKYLOSING SPONDYLITIS 51 0.0039
832 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 90 0.0039
833 METABOLIC ACIDOSIS 123 0.0038
834 PRODUCT TASTE ABNORMAL 52 0.0038
835 URTICARIA 640 0.0038
836 PERITONITIS 79 0.0038
837 MULTIPLE SCLEROSIS 182 0.0038
838 DRUG LEVEL INCREASED 63 0.0038
839 INTENTIONAL PRODUCT MISUSE 333 0.0038
840 DRUG DOSE OMISSION 627 0.0038
841 ANGER 128 0.0038
842 CARDIAC FAILURE 303 0.0038
843 MENTAL IMPAIRMENT 91 0.0038
844 ANAPHYLACTIC REACTION 207 0.0037
845 PANCREATITIS 198 0.0037
846 SENSORY DISTURBANCE 60 0.0037
847 BONE DENSITY DECREASED 117 0.0037
848 BRADYCARDIA 197 0.0037
849 BLOOD BILIRUBIN INCREASED 100 0.0037
850 ANGINA PECTORIS 106 0.0037
851 LIP SWELLING 123 0.0037
852 PANCYTOPENIA 206 0.0037
853 BLOOD GLUCOSE ABNORMAL 68 0.0037
854 IRRITABILITY 221 0.0037
855 PRODUCT USE IN UNAPPROVED INDICATION 907 0.0037
856 DEVICE ISSUE 326 0.0036
857 EYE PRURITUS 121 0.0036
858 ADVERSE DRUG REACTION 322 0.0036
859 SEPTIC SHOCK 156 0.0036
860 THROMBOCYTOPENIA 399 0.0036
861 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 61 0.0036
862 ARRHYTHMIA 168 0.0035
863 MYELODYSPLASTIC SYNDROME 51 0.0035
864 SWOLLEN TONGUE 110 0.0035
865 DISEASE PROGRESSION 416 0.0035
866 PHARYNGEAL OEDEMA 54 0.0035
867 GLYCOSYLATED HAEMOGLOBIN INCREASED 88 0.0035
868 CEREBROVASCULAR ACCIDENT 589 0.0035
869 PRESCRIBED OVERDOSE 67 0.0035
870 DRUG EFFECT INCOMPLETE 125 0.0034
871 EYE IRRITATION 198 0.0034
872 LYMPHOMA 53 0.0034
873 RENAL INJURY 101 0.0034
874 DELIRIUM 118 0.0034
875 HYPOGLYCAEMIA 164 0.0034
876 NIGHTMARE 117 0.0034
877 PSORIASIS 441 0.0034
878 METASTASES TO LIVER 59 0.0034
879 DEVICE FAILURE 51 0.0033
880 HAEMORRHAGE INTRACRANIAL 50 0.0033
881 MANIA 55 0.0033
882 DRUG INEFFECTIVE 4402 0.0033
883 PRODUCT SUBSTITUTION ISSUE 191 0.0033
884 UNDERDOSE 242 0.0033
885 AMENORRHOEA 58 0.0033
886 JAUNDICE 89 0.0033
887 DRUG EFFECT DECREASED 178 0.0033
888 MULTI-ORGAN FAILURE 57 0.0033
889 MENSTRUATION IRREGULAR 88 0.0033
890 BLOOD TRIGLYCERIDES INCREASED 58 0.0033
891 MULTIPLE SCLEROSIS RELAPSE 223 0.0033
892 DIABETES MELLITUS INADEQUATE CONTROL 57 0.0032
893 MYOCARDIAL INFARCTION 559 0.0032
894 BLINDNESS 130 0.0032
895 DRUG INTERACTION 503 0.0032
896 BLOOD GLUCOSE INCREASED 592 0.0031
897 TOOTH LOSS 65 0.0031
898 SUICIDAL IDEATION 282 0.0031
899 CIRCULATORY COLLAPSE 52 0.0031
900 PRODUCT PRESCRIBING ERROR 72 0.0030
901 ABNORMAL BEHAVIOUR 119 0.0030
902 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 164 0.0030
903 DISABILITY 59 0.0030
904 PRODUCT PHYSICAL ISSUE 60 0.0030
905 MULTIPLE ORGAN DYSFUNCTION SYNDROME 84 0.0030
906 LACTIC ACIDOSIS 95 0.0029
907 OSTEONECROSIS OF JAW 72 0.0029
908 FRACTURE 55 0.0029
909 ABNORMAL DREAMS 80 0.0029
910 PRODUCT PRESCRIBING ISSUE 63 0.0029
911 INJECTION SITE WARMTH 59 0.0029
912 DEVICE EXPULSION 184 0.0028
913 MALIGNANT NEOPLASM PROGRESSION 289 0.0028
914 CARDIO-RESPIRATORY ARREST 118 0.0028
915 ADVERSE EVENT 260 0.0028
916 INJECTION SITE REACTION 194 0.0028
917 RASH GENERALISED 73 0.0028
918 AGITATION 207 0.0028
919 DEVICE MALFUNCTION 198 0.0028
920 ACUTE MYOCARDIAL INFARCTION 82 0.0028
921 FEBRILE NEUTROPENIA 184 0.0028
922 NEOPLASM MALIGNANT 183 0.0027
923 DEATH 2357 0.0027
924 ILL-DEFINED DISORDER 166 0.0027
925 EXPIRED PRODUCT ADMINISTERED 90 0.0027
926 CARDIAC ARREST 223 0.0027
927 LUNG NEOPLASM MALIGNANT 111 0.0027
928 AGGRESSION 134 0.0027
929 ALTERED STATE OF CONSCIOUSNESS 58 0.0027
930 SEDATION 70 0.0027
931 SKIN BURNING SENSATION 191 0.0027
932 SKIN IRRITATION 122 0.0027
933 SHOCK 61 0.0026
934 PNEUMONITIS 72 0.0026
935 DERMATITIS ATOPIC 139 0.0026
936 CEREBRAL HAEMORRHAGE 94 0.0026
937 NEUTROPHIL COUNT DECREASED 107 0.0026
938 DISEASE RECURRENCE 124 0.0026
939 COMPLETED SUICIDE 217 0.0026
940 NERVOUS SYSTEM DISORDER 81 0.0026
941 VISUAL ACUITY REDUCED 86 0.0026
942 HEPATIC FAILURE 78 0.0026
943 NEOPLASM PROGRESSION 88 0.0025
944 INTERSTITIAL LUNG DISEASE 121 0.0025
945 LEUKOPENIA 124 0.0025
946 DEVICE BREAKAGE 100 0.0025
947 PANCREATITIS ACUTE 55 0.0024
948 EMOTIONAL DISTRESS 296 0.0024
949 EXPOSURE VIA SKIN CONTACT 63 0.0024
950 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 490 0.0024
951 NEUTROPENIA 328 0.0024
952 STEVENS-JOHNSON SYNDROME 53 0.0024
953 ENCEPHALOPATHY 58 0.0024
954 DEVICE LEAKAGE 102 0.0023
955 INCORRECT DRUG ADMINISTRATION DURATION 66 0.0023
956 OSTEONECROSIS 77 0.0023
957 RESPIRATORY ARREST 64 0.0023
958 ANGIOEDEMA 102 0.0023
959 PSYCHOTIC DISORDER 68 0.0023
960 HEPATOTOXICITY 51 0.0023
961 DRUG ADMINISTRATION ERROR 70 0.0023
962 APPLICATION SITE PAIN 50 0.0023
963 DEPRESSED LEVEL OF CONSCIOUSNESS 89 0.0022
964 APPLICATION SITE PRURITUS 51 0.0022
965 COMA 104 0.0022
966 ANAPHYLACTIC SHOCK 56 0.0022
967 WITHDRAWAL SYNDROME 91 0.0022
968 ELECTROCARDIOGRAM QT PROLONGED 77 0.0021
969 EXTRA DOSE ADMINISTERED 86 0.0021
970 MEDICATION ERROR 118 0.0021
971 CARDIOVASCULAR DISORDER 53 0.0021
972 ACCIDENTAL OVERDOSE 76 0.0021
973 TOXICITY TO VARIOUS AGENTS 344 0.0020
974 PRODUCT QUALITY ISSUE 275 0.0020
975 DRUG RESISTANCE 52 0.0020
976 RHABDOMYOLYSIS 82 0.0020
977 CONVULSION 108 0.0019
978 EPILEPSY 52 0.0017
979 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 78 0.0017
980 DRUG-INDUCED LIVER INJURY 52 0.0017
981 OVERDOSE 316 0.0015
982 ACCIDENTAL EXPOSURE TO PRODUCT 137 0.0013
983 BREAST CANCER 121 0.0013
984 NO ADVERSE EVENT 221 0.0012
985 PROSTATE CANCER 96 0.0012
986 SUICIDE ATTEMPT 71 0.0012
987 PRODUCT STORAGE ERROR 99 0.0011
988 DRUG WITHDRAWAL SYNDROME 88 0.0010
989 INTENTIONAL OVERDOSE 64 0.0010
990 DEVICE DIFFICULT TO USE 64 0.0010
991 BLADDER CANCER 54 0.0009
992 DRUG DEPENDENCE 102 0.0006